Purpose. Experimental and observational data link insulin, insulin-like growth factor (IGF) and estrogens to endometrial tumorigenesis. However, there are limited data regarding insulin/IGF and sex hormone axes protein and gene expression in normal endometrial tissues and very few studies have examined the impact of endometrial cancer risk factors on endometrial tissue biology.
Methods. We evaluated endometrial tissues from 77 premenopausal and 30 postmenopausal women who underwent hysterectomy for benign indications and had provided epidemiological data. Endometrial tissue mRNA and protein levels were measured using quantitative real-time PCR and immunohistochemistry (IHC), respectively.
Results. In postmenopausal women, we observed higher levels of phosphorylated IGF-I/insulin receptor (pIGF1R/pIR) in diabetic versus non-diabetic women (P-value=0.02), while women who reported regular non-steroidal anti-inflammatory drug use versus no use had higher levels of insulin and progesterone receptors (both P-values≤0.03). We also noted differences in pIGF1R/pIR staining with OC use (postmenopausal women only), and the proportion of estrogen receptor positive tissues varied by the number of live births and PTEN status (premenopausal only) (P-values≤0.04). Compared to premenopausal proliferative phase women, postmenopausal women exhibited lower mRNA levels of IGF1, but higher IGFBP1 and IGFBP3 expression (all P-values≤0.004), and higher protein levels of the receptors for estrogen, insulin and IGF-I (all P-values≤0.02). Conversely, pIGF1R/pIR levels were higher in premenopausal proliferative phase versus postmenopausal endometrium (P-value=0.01).
Conclusions. These results highlight links between endometrial cancer risk factors and mechanistic factors that may contribute to early events in the multi-stage process of endometrial carcinogenesis.